Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ong

Showing results (811-820 of 862) with videos related to

Pageof 87
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
One-year clinical outcome of various doses and pharmacokinetic release formulations of paclitaxel eluted from an erodable polymer - Insight in the Paclitaxel In-Stent Controlled Elution Study (PISCES)Jiro Aoki, Andrew T L Ong, Alexandre Abizaid, et al.
The Lancet. Global Health|June 20, 2020
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling studyAndrew Clark, Mark Jit, Charlotte Warren-Gash, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
Drug-eluting stent implantation for chronic total occlusions: comparison between the Sirolimus- and Paclitaxel-eluting stentAngela Hoye, Andrew T L Ong, Jiro Aoki, et al.
Nephrology (Carlton, Vic.)|July 25, 2015
Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) studyAndrea K Viecelli, Elaine M Pascoe, Kevan R Polkinghorne, et al.
Journal of the American College of Cardiology|February 21, 2004
Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarctionPedro A Lemos, Francesco Saia, Sjoerd H Hofma, et al.
American Heart Journal|June 20, 2006
The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phaseAndrew T L Ong, Patrick W Serruys, Frederick W Mohr, et al.
European Journal of Endocrinology|April 25, 2014
Adiponectin gene variants and the risk of coronary heart disease: a 16-year longitudinal studyChloe Y Y Cheung, Elaine Y L Hui, Bernard M Y Cheung, et al.
The Journal of Invasive Cardiology|August 5, 2005
One-year clinical outcome after coronary stenting of very small vessels using 2.25 mm sirolimus- and paclitaxel-eluting stents: a comparison between the RESEARCH and T-SEARCH registriesGastón A Rodriguez-Granillo, Marco Valgimigli, Héctor M Garcia-Garcia, et al.
Nature|December 9, 2017
Programmable self-assembly of three-dimensional nanostructures from 10,000 unique componentsLuvena L Ong, Nikita Hanikel, Omar K Yaghi, et al.
Circulation. Arrhythmia and Electrophysiology|February 23, 2024
Predicting Major Adverse Events in Patients Undergoing Transcatheter Left Atrial Appendage OcclusionKamil F Faridi, Emily L Ong, Sarah Zimmerman, et al.
Pageof 87

Showing results (811-820 of 862) with videos related to

Sort By:
Pageof 87
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
One-year clinical outcome of various doses and pharmacokinetic release formulations of paclitaxel eluted from an erodable polymer - Insight in the Paclitaxel In-Stent Controlled Elution Study (PISCES)Jiro Aoki, Andrew T L Ong, Alexandre Abizaid, et al.
The Lancet. Global Health|June 20, 2020
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling studyAndrew Clark, Mark Jit, Charlotte Warren-Gash, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
Drug-eluting stent implantation for chronic total occlusions: comparison between the Sirolimus- and Paclitaxel-eluting stentAngela Hoye, Andrew T L Ong, Jiro Aoki, et al.
Nephrology (Carlton, Vic.)|July 25, 2015
Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) studyAndrea K Viecelli, Elaine M Pascoe, Kevan R Polkinghorne, et al.
Journal of the American College of Cardiology|February 21, 2004
Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarctionPedro A Lemos, Francesco Saia, Sjoerd H Hofma, et al.
American Heart Journal|June 20, 2006
The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phaseAndrew T L Ong, Patrick W Serruys, Frederick W Mohr, et al.
European Journal of Endocrinology|April 25, 2014
Adiponectin gene variants and the risk of coronary heart disease: a 16-year longitudinal studyChloe Y Y Cheung, Elaine Y L Hui, Bernard M Y Cheung, et al.
The Journal of Invasive Cardiology|August 5, 2005
One-year clinical outcome after coronary stenting of very small vessels using 2.25 mm sirolimus- and paclitaxel-eluting stents: a comparison between the RESEARCH and T-SEARCH registriesGastón A Rodriguez-Granillo, Marco Valgimigli, Héctor M Garcia-Garcia, et al.
Nature|December 9, 2017
Programmable self-assembly of three-dimensional nanostructures from 10,000 unique componentsLuvena L Ong, Nikita Hanikel, Omar K Yaghi, et al.
Circulation. Arrhythmia and Electrophysiology|February 23, 2024
Predicting Major Adverse Events in Patients Undergoing Transcatheter Left Atrial Appendage OcclusionKamil F Faridi, Emily L Ong, Sarah Zimmerman, et al.
Pageof 87